Showing results (191-200 of 376) with videos related to
Sort By:
Pageof 38
Archives of Physical Medicine and Rehabilitation|June 1, 1995
Biofeedback therapy in poststroke rehabilitation: a meta-analysis of the randomized controlled trialsM Glanz, S Klawansky, W Stason, et al.The Journal of Oral Implantology|April 27, 2024
Evaluation of 4 and 8 Weeks of Healing in a Murine Implant ModelJaclyn C Chalmers, Davi Neto de Araújo Silva, Maísa Casarin, et al.AJR. American Journal of Roentgenology|March 25, 2005
Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CTDavid W Barker, Ronald J Zagoria, Kathryn A Morton, et al.Clinical Nuclear Medicine|August 21, 2014
CT, MRI, and 18F-FDG PET/CT in a patient with nested stromal epithelial tumor of the liverAmin Samarghandi, David W Barker, Elizabeth A Hingsbergen, et al.BMC Health Services Research|June 2, 2018
Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisalsLiz Morrell, Sarah Wordsworth, Anna Schuh, et al.Journal of Geriatric Psychiatry and Neurology|July 27, 2000
Family history of dementia and current depression in nondemented community-dwelling older adultsD G Harwood, W W Barker, R L Ownby, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 1, 1992
Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer diseaseR Duara, W W Barker, J Chang, et al.British Journal of Anaesthesia|January 1, 1975
Nuclear magnetic resonance studies of anaesthetic interactions with haemoglobinR W Barker, F F Brown, R Drake, et al.Journal of the International Neuropsychological Society : JINS|January 31, 2004
Semantic interference deficits and the detection of mild Alzheimer's disease and mild cognitive impairment without dementiaDavid A Loewenstein, Amarilis Acevedo, Cheryl Luis, et al.BMC Health Services Research|March 30, 2019
Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisalsLiz Morrell, Sarah Wordsworth, Anna Schuh, et al.Pageof 38